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Summary
The neurotrophin receptor TrkA (also known as NTRK1) is known to be crucially involved in several physio-pathological processes.
However, a clear description of the early steps of ligand-induced TrkA responses at the cell plasma membrane is missing. We have
exploited single particle tracking and TIRFmicroscopy to study TrkAmembrane lateral mobility and changes of oligomerization state upon
binding of diverse TrkA agonists (NGF, NGF R100E HSANVmutant, proNGF and NT-3). We show that, in the absence of ligands, most of
the TrkA receptors are fast moving monomers characterized by an average diffusion coefficient of 0.47 mm2/second; about 20% of TrkA
molecules move at least an order of magnitude slower and around 4% are almost immobile within regions of about 0.6 mm diameter.
Ligand binding results in increased slow and/or immobile populations over the fast one, slowing down of non-immobile trajectories and
reduction of confinement areas, observations that are consistent with the formation of receptor dimeric and oligomeric states. We
demonstrate that the extent of TrkA lateral mobility modification is strictly ligand dependent and that each ligand promotes distinct
trajectory patterns of TrkA receptors at the cell membrane (ligand ‘fingerprinting’ effect). This ligand signature of receptor dynamics
results from a differential combination of receptor-binding affinity, intracellular effectors recruited in the signalling platforms and
formation of signalling and/or recycling endosome precursors. Thus, our data uncover a close correlation between the initial receptor
membrane dynamics triggered upon binding and the specific biological outcomes induced by different ligands for the same receptor.
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Introduction
A major open question in cell biology is how different growth-
factor receptors achieve molecular specificity even though they
activate apparently identical signalling events. Symmetrically,
different ligands can activate the same receptor and result in distinct
biological outcomes, although bearing similar receptor-binding
affinities. Indeed, the mechanisms by which receptors transduce
ligand-specific signals are not satisfactorily understood. Here we
address this question by studying, at the single molecule level, the
dynamics of the neurotrophin receptor tropomyosin-related kinase
A (TrkA; also known as neurotrophic tyrosine kinase, receptor,
type 1, NTRK1) in the cell membrane of living cells.
TrkA plays a crucial role in the development and survival of
sympathetic and sensory neurons, neuronal plasticity, and
differentiation of central nervous system cholinergic neurons
(Klein et al., 1991; Reichardt, 2006). Although nerve growth
factor (NGF) (Levi-Montalcini, 1987) is the main ligand for TrkA,
other ligands such as proNGF, the unprocessed form of NGF, and
the neurotrophin NT-3 can also activate it. Each of these ligands
exerts widely different cellular outcomes, which can only partly be
accounted for by a varying contribution from TrkA co-receptor
p75NTR (Fahnestock et al., 2001; Harrington et al., 2011; Kuruvilla
et al., 2004; Lee et al., 2001). ProNGF can cause actions that are
quite opposite to those driven by NGF (Lee et al., 2001) but it might
also determine, albeit less effectively than mature NGF, TrkA-
dependent neuronal survival (Fahnestock et al., 2001). The recent
observation that NGF and proNGF promote different short-term
gene expression profiles suggests that they activate different
signalling pathways (D’Onofrio et al., 2011); to date, however, the
description of the distinct molecular interactions between TrkA and
proNGF or mature NGF leading to the observed different biological
outcomes is still under debate. NT-3 is known to promote, similarly
to NGF, TrkA phosphorylation, and ERK, PLC-c and Akt
signalling activation (Harrington et al., 2011; Kuruvilla et al.,
2004), but in contrast to NGF, NT-3 is unable to elicit retrograde-
transport-dependent neuronal survival. Moreover, a mutant form of
NGF (NGF R100E or ‘painless NGF’) (Covaceuszach et al., 2010,
BBRC; Capsoni et al., 2011) related to the human genetic disease
hereditary sensory autonomic neuropathy type V (HSAN V)
(Einarsdottir et al., 2004) was shown to bind TrkA with affinity
close to that of wild-type NGF, but to activate a specific change in
the downstream pathways: that is, a significant, selective reduction
of PLC-c-dependent signalling activation, whereas ERK and Akt
pathways are relatively unchanged (Capsoni et al., 2011). This was
functionally related to the relative inability of this mutant form of
NGF to activate nociceptive pathways.
The dynamics of TrkA in response to NGF was recently
studied in living cells by different approaches. GFP-fused TrkA
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receptors were imaged in the presence or absence of NGF (Jullien
et al., 2003). Membrane movements of bona fide NGF–TrkA
complexes were investigated at the single-molecule level by NGF
conjugated to Cy3 fluorophore (Shibata et al., 2006; Tani et al.,
2005) or to quantum dots (Qdots) (Cui et al., 2007; Echarte et al.,
2007; Rajan et al., 2008; Sundara Rajan and Vu, 2006). More
recently, the simultaneous imaging of a GFP–TrkA fusion and
Cy3.5–NGF made it possible to discriminate the retrograde
transport of vesicles containing the receptor alone or the ligand–
receptor complex (Nomura et al., 2011). However, none of these
experimental approaches has yet identified how the lateral
mobility of TrkA receptors at the cell membrane and the very
early steps of receptor internalization are influenced by the
binding of different ligands. Indeed, fusion of GFP to TrkA
receptors labels both intracellular and membrane pools, and
single receptors cannot be tracked for a sufficiently long time,
because of the poor photophysical properties of GFP at the
single-molecule level. The alternative use of labelled NGF allows
the study of TrkA receptor only in its activated form, so that the
net effect of ligand binding on the receptor membrane mobility
cannot be investigated. For these reasons, there are still relevant
questions that must be explored: are TrkA membrane movements
related to ligand-specific receptor activation processes and to the
subsequent signalling cascade? How do different ligands affect
TrkA dynamics, in comparison to NGF? Are NGF and its
precursor proNGF different signalling molecules as far as TrkA
binding is concerned?
In the study reported here, by directly imaging single TrkA
molecules on the membrane of living cells, we investigated
whether and how receptor-membrane dynamics is linked to the
specific mode of binding and activation exerted by NGF,
‘painless NGF’, proNGF and NT-3 ligands. To do so, we
exploited a novel strategy to label TrkA (Callegari et al., 2012),
which allows imaging and tracking of single receptor molecules
both in the absence and in presence of ligands. We provide a
quantitative comparison of the diffusive properties and of the
oligomeric state of free and NGF-bound TrkA receptors.
Moreover, we describe the different receptor-motion patterns
induced by the different ligands. TrkA dynamics changes were
investigated, also in response to ligands, after inducing a set of
biochemical modifications of the cell environment, affecting
receptor kinase activity, clathrin-coated pit (CCP) formation, or
actin-meshwork integrity. By using a novel single particle
tracking (SPT) analysis approach, we demonstrate that the
pattern of receptor dynamics in the membrane carries a
signature of the ligand by which it was activated.
Results
Individual ACP–TrkA trajectories display different dynamic
regimes at the membrane of SH-SY5Y cells
We recently demonstrated that the acyl carrier protein (ACP)
fused at the N-terminus of TrkA preserves the full functional
responsiveness and signalling activation of the receptor, and
allows its imaging at the single-particle level in the plasma
membrane of living cells (Callegari et al., 2012). Here, the ACP–
TrkA construct was transiently transfected into undifferentiated
SH-SY5Y neuroblastoma cells. The receptor pool at the cell
surface was selectively labelled by biotinylation of the ACP tag
and subsequent addition of streptavidin-coated Qdots (S-Qdots)
emitting at 655 nm. Bulk labelling was obtained using a
concentration of 20 nM S-Qdots in the final labelling step.
Fig. 1A shows our typical microimages: cells expressing the
construct display S-Qdot red staining on the plasma membrane,
whereas the cell body is green as a result of the simultaneous
expression of GFP (the latter was inserted in the same expression
plasmid). In order to detect and track single ACP–TrkA
molecules in the cell membrane, we lowered the S-Qdots
concentration down to 2 nM and selectively imaged the basal
membrane of the cells facing the coverslip by total internal
reflection fluorescence (TIRF) microscopy (Fig. 1B). We
analysed cells displaying 5–50 dots on the basal membrane
(0.01–0.1 dots/mm2), as occurred with the same labelling reaction
in the case of a SH-SY5Y stable cell line expressing low levels of
the ACP–TrkA construct. The density of labelled receptors is an
important issue when performing SPT studies (Jaqaman et al.,
2011; Kasai et al., 2011) and in our case the selection of cells
with low-expression profile of the construct is necessary also to
avoid autoactivation of the receptor kinase activity in the absence
of NGF (supplementary material Fig. S1). The use of S-Qdots as
a probe allowed long-term tracking of individual ACP–TrkA
receptors and revealed a rather heterogeneous behaviour. A pool
of receptors was almost immobile during the whole observation
period (Fig. 1C); long trajectories also showed multimodal
dynamics, switching from periods of faster diffusion to phases
of transient arrest of lateral diffusivity (Fig. 1D). TAD (transient
arrest of diffusion) analysis was performed to separate trajectory
segments corresponding to confinement regions from those
corresponding to diffusive or drifting traits. The resulting
subtrajectories, if not assigned to TAD events, were pooled
together with other receptor trajectories (usually shorter than the
multimodal ones) that displayed a unique mode of diffusion:
either slow or fast diffusing, sometimes within a confinement
area and, more rarely, drifting (Fig. 1E, top, middle, bottom
panels respectively). The quantitative parameters describing all
classes of trajectories and subtrajectories and their respective
frequency are summarized in Table 1 and further explained in the
Materials and Methods and in supplementary material Fig. S7;
supplementary material Table S1 summarizes the results arising
from multimodal trajectories only. The whole set of monomodal
trajectories and subtrajectories analysed are hereafter referred to
as (sub)trajectories, and their numbers are reported in the column
‘(sub)traj’ of Table 1.
NGF binding decreases TrkA diffusivity and confinement
length
The lateral mobility of ACP–TrkA was first investigated in the
absence and presence of saturating concentrations of NGF
(125 ng/ml). The ligand was added to the cell medium and
receptor mobility was monitored immediately afterwards, within
a time window of 15 minutes. We found that NGF binding to
TrkA resulted in macroscopic clustering of receptor molecules
(Fig. 2A) and in a decrease in its diffusivity (Fig. 2B,C; Table 1).
When analysing the immobile receptor population (Fig. 1C), we
observed that NGF addition causes an eightfold increase in the
total time–length fraction of these trajectories from 3.8% to
29.7% (Table 1); furthermore, the average confinement length
,L. of immobile receptors is halved upon ligand binding, from
0.5960.08 mm to 0.2960.02 mm (uncertainty: s. e.; Fig. 2B). As
for the TAD events and the slow and fast diffusing TrkA
trajectories (Fig. 1D–E), no significant variation of their
confinement length was observed, whereas their total
time–length frequency was redistributed: both TAD events and
Journal of Cell Science 126 (19)4446
Jo
u
rn
a
l
o
f
C
e
ll
S
ci
e
n
ce
slow-diffusing trajectories increase by a factor 1.7, while fast-
diffusing receptor molecules were halved upon NGF addition
(Table 1). Similarly, both the total time fraction and length of the
drifted trajectories were shortened by NGF treatment (Table 1).
We recorded a bimodal behaviour in the distribution of the
diffusion coefficient D of non-immobile TrkA receptors
(Fig. 2C), both in the absence and in the presence of NGF.
Notably, NGF addition causes a 1.7-fold decrease of the integral
of the peak corresponding to faster diffusion and a 2.4-fold
increase of the integral of the lower-diffusivity peak, together
with a marked increase in the separation of the two peaks.
NGF binding induces receptor di- or oligomerization
In order to assess whether and how the receptor oligomeric status is
related to the above-described changes of lateral diffusion, we
changed the labelling of the receptor and covalently conjugated a
CoA derivative of the Atto633 fluorophore (CoA-Atto633) to the
ACP–TrkA expressed at the membrane of SH-SY5Y cells. Indeed,
organic fluorophores produce more monodispersed photophysical
features than Qdots, and thus are more suitable to directly link the
fluorescence intensity of the tracked objects to the oligomeric forms
of the receptor (Resch-Genger et al., 2008). The average intensity
for single fluorophores measured with our TIRF microscope set-up
was around 3000 arbitrary units in all our experiments. As an
example, the left panel in Fig. 2D shows the intensity signal
recorded in the case of a spot comprising two fluorophore
molecules whose individual bleaching can be monitored.
In order to analyse correlations between oligomeric status and
the diffusion coefficient of Atto633-labelled TrkA receptors, we
plotted the two-dimensional (2D) distribution of D and spot
intensity ,I. averaged on each trajectory (Fig. 2D). In the case
of unstimulated receptors, the peak of this 2D distribution lay at
an,I. value corresponding to single molecules and at a D value
consistent with the fastest mobile population of TrkA (Fig. 2D,
central panel). From these data we conclude that about 70% of
TrkA receptors (as calculated from the integral of the distribution
in the central panel of Fig. 2D within the black rectangle) is
present as fast diffusing monomers at the cell membrane in the
absence of any ligand. The remaining detected particles, with
lower mobility, appeared to have variable intensities spanning
values between the ones expected for monomers and dimers or,
albeit very infrequently, larger oligomers. When imaging in the
presence of NGF was performed, the intensity of tracked
Atto633-ACP–TrkA molecules displaying both fast and slow
diffusion was significantly modified (Fig. 2D, right plot). On the
one hand, the fast population of tracked receptors had a more
heterogeneous average intensity, with values intermediate
between the intensity of monomeric and dimeric receptor
forms (indicated by the two white crosses on the graph). This
is probably a result of the monomer–dimer equilibrium
undergone by the TrkA receptors upon ligand stimulation (or
possibly by the photobleaching of a single fluorophore in a
dimer). Indeed, the shift towards the dimer fluorescence
intensity corresponds to a slight decrease of D, possibly linked
to the increase of the molecular mass of the tracked objects and/
or to interactions with sub-membrane effectors. On the other
hand, the receptor population with lower diffusivity was not
only greatly increased (in agreement with data reported in
Fig. 2B,C), but also showed a wide range of average
fluorescence intensities, spanning from monomers to
oligomers containing up to about eight individual receptor
molecules.
Fig. 1. Selective labelling of membrane-localized ACP–
TrkA receptor for SPT experiments. (A) Confocal images
of SH-SY5Y cells transiently transfected with ACP–TrkA-
IRES-GFP construct. The green channel is GFP
fluorescence; the red channel is ACP–TrkA receptor at the
cell membrane after its biotinylation and subsequent
conjugation with 20 nM S-Qdots655. Scale bar: 10 mm.
(B) Typical S-Qdots distribution on the basal membrane of
living SH-SY5Y cells maintained at 37 C˚ upon labelling of
biotinylated ACP–TrkA with 2 nM S-Qdots (red channel,
imaged by TIRF; DIC transmission microscopy image in
grey and epifluorescence GFP channel in green are shown as
references). Scale bar: 20 mm in grey channel; 10 mm in red
and green channels. (C–E) Representative trajectories of
tracked receptors, with spot colour coding for the frame
number (3000 frames being 63 seconds). Trajectories were
classified into different diffusive categories, e.g. immobile
(C) or multimodal (D); the latter ones may be composed of
subdiffusive or slow (E, top panel), free diffusive or fast
(E, middle panel) and superdiffusive or drifted (E, bottom
panel) dynamics modes. (F) Colour-coded map representing
the frame number for spots in the trajectories.
Ligand fingerprinting on TrkA diffusion 4447
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Effect of other TrkA ligands on TrkA lateral diffusion
We next investigated how TrkA receptor dynamics is influenced
by three other ligands (whose biological effect through TrkA
binding is summarized in supplementary material Fig. S2): a
mutant form of NGF bearing the R100E point mutation (NGF
R100E), the unprocessed pro-neurotrophin proNGF, and the
neurotrophin NT-3. The distributions of confinement length and
of D values obtained from the analysis of tracked receptors in the
three cases are reported in Fig. 3, A–C and D–F, respectively (data
obtained for TrkA in the absence and in the presence of NGF are
also reported in each panel as a reference). We found that all
ligands induce increased immobilization (Fig. 3A–C; Table 1) and
a redistribution between the two peaks of TrkA diffusion in favour
of the lower diffusivity one (Fig. 3D–F; Table 1) when compared
to the non-stimulated receptor. However, whereas NGF R100E
induced an increase of the total time fraction of both TAD events
and slow trajectories in a similar way to NGF, proNGF and NT-3
elicited the increase only of TAD occurrence (Table 1, columns
Time% of TAD events and slow trajectories). Clearly, the extent of
receptor mobility modification is very different for the various
ligands, with NGF R100E having the highest similarity to the
NGF-driven behaviour, and proNGF and NT-3 being substantially
different from NGF.
In order to better evaluate the differential effects exerted by the
four analysed ligands when compared with each other and with
the non-stimulated receptor, we generated the 2D distribution
of two parameters summarizing the diffusive behaviour of
all (sub)trajectories obtained for each case (Fig. 4). These
parameters are the D coefficient, and the c coefficient
calculated using the MSS algorithm (Ewers et al., 2005): the
smaller the c value, the more sub-diffusive is the motion of the
receptor (as it is for confined ones), with a theoretical c,0.5 for
free-diffusing particles and c.0.5 for drifted ones. All graphs
were divided into eight dynamics regions (delimited by the grey
rectangles numbered in Fig. 4A) and the relative weight of
trajectories within each region was quantified and reported as a
stack-column graph in Fig. 4G (and as percentages in
supplementary material Table S2). It is evident that NGF and
NGF R100E induce the most prominent shift towards the slow-
diffusing receptor pool (regions 2–3) and the almost-immobile
receptors fraction (regions 4–6); however, this analysis reveals a
subtle difference, in that the slower trajectories are differently
redistributed in the D-c distributions for these two ligands.
ProNGF has a slowing effect on TrkA mobility similar to that of
NGF, but weaker; finally NT-3-induced D-c distribution
resembles that of the receptor in the absence of any ligand,
Fig. 2. Effects of NGF on ACP–TrkA mobility at 37 C˚. (A) TIRF microimages showing the distribution of ACP–TrkA receptor labelled with 2 nM S-Qdots655
before (red channel, left panel) and after NGF administration (red channel, right panel) at the SH-SY5Y plasma membrane. Areas outside cells are shown in grey.
NGF-induced receptor clustering is indicated by arrowheads in right panel; scale bar: 5 mm. (B) Distributions of the receptor confinement length L for ‘immobile’
trajectories of S-Qdot-labelled ACP–TrkA receptors in the presence (red curve, n5121) or absence (black curve, n513) of NGF, with areas under the curve
normalized to the fractions of spots assigned to immobile trajectories. (C) Distribution of the short-lag-time diffusion coefficient (D) of S-Qdot-labelled ACP–
TrkA receptors for non-immobile trajectories in the presence (red curve, n5788) or absence (black curve, n5664) of NGF. The areas under the reported
distributions are normalized to the fraction of spots in non-immobile trajectories. The percentages were calculated considering the areas under the curve above and
below D50.1 mm2/second. (D) Fluorescence intensity (I) analysis of single Atto633 molecules and Atto633-labelled ACP–TrkA observed by TIRF microscopy.
Left panel: typical time-course of I for a spot comprising two molecules of the organic dye CoA-Atto633 adhered to the bottom of the Petri dish. Right panels: 2D
distribution of the average fluorescence intensity ,I. of Atto633-labelled ACP–TrkA trajectories and of D in the untreated (central panel, n57367) and NGF-
treated (right panel, n510,288) cases. NGF treatment induces receptor dimerization within higher-D trajectories (the white line connects the fluorescence intensity
of the monomer to that of the dimer, which appears to have a halved D) and oligomerization (white rectangular area) corresponding to increased average
fluorescence and decreased diffusivity of receptor aggregates.
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except for a higher population in region 5 and a lower one in
region 2. This analysis highlights the existence of distinct, ligand-
dependent modes of diffusion and confinement for ACP–TrkA
upon ligand stimulation.
TrkA lateral mobility is modified by drug treatments
affecting TrkA kinase activity, the early events of
endocytosis and the actin meshwork
We next investigated how the different motion and diffusivity
patterns described in the previous section depend on the TrkA
receptor state and/or on the structural components of the plasma
membrane. We first took into account the intrinsic receptor
kinase activity. SH-SY5Y cells transfected with ACP–TrkA
construct were treated overnight with the kinase inhibitor K252a,
which resulted in the complete inhibition of ACP–TrkA
phosphorylation (supplementary material Fig. S3A). Cells were
then labelled with S-Qdots and individual receptor molecules
imaged either in the absence or in the presence of NGF. K252a
treatment affected the mobility of the receptor, mainly by
increasing the population in diffusivity region 3 (Fig. 5A,G);
more importantly, this treatment dramatically impaired
the observed NGF-induced receptor slowing down and
immobilization (Fig. 5B,G; Table 1; supplementary material
Fig. S4A,B; Table S2).
We then investigated how inhibition of CCPs formation affects
TrkA membrane mobility and NGF-associated alterations in
TrkA diffusion patterns. To this end, SH-SY5Y cells transfected
with ACP–TrkA construct were treated with chlorpromazine
(Chlprz), a selective inhibitor of CCP formation and of clathrin-
dependent early endocytosis, as assessed by the impairment of
Alexa-Fluor-488-labelled transferrin internalization in SH-SY5Y
cells (supplementary material Fig. S3B). We found that this
treatment also had only a slight effect onto TrkA lateral mobility
in resting conditions (Fig. 5C,G), mainly decreasing the slow
population in regions 2 and 3 in favour of the fast population in
region 1. In contrast, inhibition of CCPs formation had a much
stronger influence on the binding of NGF to the ACP–TrkA
receptor (Fig. 5D,G; Table 1; supplementary material Fig.
S4C,D; Table S2), by almost completely inhibiting the
populations of regions 2 and 6, and changing the details of the
distribution within regions 3 and 4.
Finally, SH-SY5Y cells expressing ACP–TrkA were treated
with cytochalasin D (Cyt-D) in order to disrupt the meshwork of
actin filaments that are associated with the cytoplasmic face
of the plasma membrane and contribute to its structure
(supplementary material Fig. S3C). We found that treatment
with Cyt-D leads to a significant decrease of the fast-diffusing
ACP–TrkA population in resting conditions (Fig. 5E,G;
supplementary material Fig. S3E). However, a number of
ACP–TrkA receptors remained sensitive to NGF stimulation
(Fig. 5F,G; supplementary material Fig. S4E–F), as demonstrated
by the higher immobilization of receptors (supplementary
material Fig. S3E) and by the higher proportion of receptors
residing in areas of low c and D, such as regions 3, 4, 6 in
presence of NGF.
Taken together, these results indicate that, whereas K252a and
Chlprz treatments impair NGF-induced TrkA dynamic behaviour,
Cyt-D administration affects mainly the fast diffusive
component, while poorly influencing the NGF-dependent
immobile and slow receptor populations. For this reason, the
effect of Cyt-D can be best appreciated in the absence of any
ligand addition.
Discussion
In this work we explored the lateral mobility of TrkA receptors at
the basal membrane of SH-SY5Y cells; in particular, we
examined their response to a set of diverse biologically
relevant TrkA ligands. We used TIRF microscopy and SPT
together with the ACP–TrkA construct, which allows the
selective labelling and imaging of single receptor molecules
translocated to the plasma membrane (Callegari et al., 2012). We
used two different receptor labelling strategies exploiting the
versatility of the ACP tag (George et al., 2004; Johnsson et al.,
2005). In one case, we biotinylated ACP–TrkA using a CoA-
biotin substrate and coupled them to S-Qdots; in the other, we
covalently conjugated ACP–TrkA to a CoA derivative of the
Atto633 synthetic fluorophore. Tracking the receptor with these
two probes allowed us to obtain different and complementary
observations on TrkA dynamics. By long-term tracking of the
receptor labelled with S-Qdots we observed that TrkA receptors
display different dynamic behaviours in resting conditions
(Fig. 1C–F) and that the population of each dynamics category
Fig. 3. Effect of ligands on ACP–TrkA mobility. (A–C) Distributions of the
confinement length L for ‘immobile’ trajectories of S-Qdot-labelled ACP–
TrkA receptors (blue curves) upon treatment with NGF R100E mutant (NGF
R100; A; n5121), pro-NGF (B; n559) and neurotrophin-3 (NT-3; C; n537).
Normalization as in Fig. 2B, whose content is reproduced here as dashed
curves for comparison. (D–F) Diffusion coefficient (D) distribution (blue
curves) of non-immobile trajectories of S-Qdot-labelled ACP–TrkA receptors
upon treatment of cells with NGF R100E (D; n51142), pro-NGF (E;
n51175) and NT-3 (F; n51483). Normalization as in Fig. 2C, whose content
is reproduced here as dashed curves for comparison.
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changes in response to ligand addition and drug treatment
(Table 1; Figs 2–5). In addition, by tracking Atto633-ACP–TrkA
we could gain insights on the oligomeric status of TrkA, in the
absence or presence of NGF (Fig. 2D).
We conclude that in the absence of any stimulus, the diffusion
coefficient for TrkA receptors has mostly a bimodal distribution,
characterized by two components differing by one order of
magnitude (Fig. 2C, top graph). The fast diffusion peak is the
most populated: we found TrkA molecules moving with
diffusivity higher than 0.1 mm2/second for more than 70% of
the time, and this population corresponds mostly to TrkA
monomers (Fig. 2D, black rectangle in the central panel).
ACP–TrkA receptors follow (sub)trajectories contributing to
the slow diffusion peak for,1/5 of the time (Fig. 2C, top graph);
these stem from receptors in both monomeric and di/oligomeric
states (Fig. 2D, white rectangle in the central panel). These
receptors are either moving slowly at the cell membrane or
undergoing TAD events (Table 1, first row). The remaining
trajectories are followed by TrkA molecules that are essentially
immobile within a small area of ,0.6 mm diameter (Fig. 1C);
these are represented in Fig. 2B by the black histogram and are
detected for ,4% of the time (see Table 1).
NGF triggers a reduction of the fast diffusing population,
greatly increasing the slow/immobile one (about eightfold),
displaying a more restricted confinement (Fig. 2B,C bottom
panel; Table 1). Furthermore, a striking shift of the monomer–
dimer equilibrium towards the dimeric form can be observed in
the fast-diffusing receptor population, whereas receptor clusters
containing several – up to eight – receptor molecules make up the
slow and immobile populations (Fig. 2D, right panel). These
considerations provide a direct demonstration, at the single
particle level, of the NGF-induced TrkA dimerization and
subsequent clustering at the cell membrane. Notably, our data,
obtained from cells displaying low expression of ACP–TrkA, do
not support the recent suggestion that NGF only induces dimer
phosphorylation of preformed unstimulated TrkA dimers (Shen
and Maruyama, 2011).
The observation that ligand binding leads to immobilization
and slowing down of lateral mobility was reported for several
membrane receptors other than TrkA (Chung et al., 2010; Kasai
et al., 2011; Lill et al., 2005; Winter et al., 2011). To date,
however, the specific influence of different ligands binding the
same type of receptor was poorly investigated, and, to our
knowledge, limited to a comparison between agonist and
antagonist ligands (Jacquier et al., 2006). Here, we investigated
TrkA lateral diffusion induced by the addition and consequent
binding of four agonist ligands: NGF, ‘painless’ mutant
NGFR100E, proNGF and NT-3 (Figs 2–4). As schematically
depicted in supplementary material Fig. S2, these ligands are
known to show different affinity for TrkA, as well as specific
modes of receptor activation and/or recruitment of intracellular
signalling effectors. Therefore they can be considered full (NGF),
partial (NT-3 and proNGF) or biased (NGF R100E) TrkA
agonists. Our experiments clearly show a ligand ‘fingerprinting’
effect on the modifications in TrkA lateral mobility at the single
molecule level. Each ligand prompts particular changes in
Fig. 4. Effects of ligands on ACP–TrkA dynamics modes. (A–E) Total D-c distributions according to MSS-TAD analysis of ACP–TrkA trajectories in non-
stimulated cells (A; n5677), and after addition of NGF (n5909), NGF R100E (n51263), proNGF (n51234) or NT-3 (n51520; B–E, respectively).
Dynamics regions (numbered from 1 to 8 in A) are superimposed on each plot. The diffusion coefficient D reflects the short-term diffusivity and the c factor
reflects the long-term trajectory behaviour (c approximately greater or less than 0.5 for Brownian, drifted, and subdiffusive/confined dynamics, respectively).
(F) Logarithmic-scale colour code for the frequency of the total D-c distributions, normalized to 1 at the peak. (G) Frequency percentage of different dynamics
modes for ACP–TrkA receptors, as calculated from the integral of the experimental D-c distribution in each numbered region of A–E. These values are reported
more fully in supplementary material Table S2.
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receptor diffusion, as well as in the fraction and type of immobile
trajectories (Fig. 3). The observed heterogeneous responses
suggest a complex set of TrkA-receptor dynamics modes upon
ligand stimulation. These are only partially described by the
diffusion-coefficient distributions and by histograms of the
confinement length; therefore, we analysed the 2D distribution
of c and D parameters for all TrkA (sub)trajectories (Fig. 4).
Moreover, we investigated how TrkA lateral mobility is
influenced by drug treatments inhibiting its kinase activity or
the early events of clathrin-dependent endocytosis; similarly, we
studied the effects of actin meshwork disruption under the plasma
membrane (supplementary material Figs S3, S4; Fig. 5). Thus,
we were able to quantitatively analyse how ACP–TrkA receptor
molecules redistribute among all dynamic and immobile
categories (plot regions numbered from 1 to 8 in Fig. 4A and
Fig. 5A) as a result of specific ligand addition (Fig. 4) or drug
treatment (Fig. 5). The results allowed us to hypothesize
a biological significance for almost all of these dynamics
regions and to propose a molecular mechanism explaining the
heterogeneous responses of TrkA dynamics, as schematically
depicted in Fig. 6 and explained in the following.
Region 1 comprises D coefficients between 0.1 and 1 mm2/
second, and c values dispersed around 0.5, with a significant tail
towards lower values down to 0.25. It is populated by fast
almost free-diffusing trajectories, although relatively large
regions of confinement (up to several microns) were
occasionally detected for them (Table 1, ,L. column for fast
trajectories). Region 1 is significantly depleted by almost every
ligand treatment (Fig. 4); crucially, the higher the ligand affinity
for TrkA, the lower is the frequency of trajectories populating
region 1 (compare ligand Kd values in supplementary material
Fig. S2 with Fig. 4G and to Table 1, column Time% for fast
trajectories). We suggest that this region constitutes the
‘monomer reservoir’ of ACP–TrkA receptors available for
ligand capture (it may also include freely diffusing dimers, with
no or low interactions with other membrane or cytoplasmic
components – see Fig. 6). Differently from region 1, the
correlation of ligand-induced changes of the other dynamics
regions (2–8) with ligand affinity is not obvious (Table 1). Thus,
other factors besides ligand affinity have to be considered to
understand the ligand ‘fingerprinting’ effect.
Region 2 includes trajectories with a low degree of
confinement (c,0.5 or slightly lower) but displaying a
significantly lower diffusion coefficient (1023–0.561021 mm2/
second). It becomes highly populated upon NGF addition
(Fig. 4B,G), but not when cells are previously treated with the
tyrosine kinase inhibitor K252a (Fig. 5B,G; its population falls
from ,13% to 3.5% as reported in supplementary material Table
S2), or when the previous treatment with Chlprz causes the
disassembly of CCPs (Fig. 5C,D,G).
Region 5 includes receptor trajectories characterized by
relatively high short-lag-time diffusion coefficients (D between
0.013 and 0.3 mm2/second) and restricted motion (very low c
values). This region is virtually unpopulated when the TrkA
receptor is not stimulated (Fig. 4A,G). It becomes highly
populated upon NGF addition (Fig. 4B,G), but not if K252a is
added to the cell culture prior to NGF (Fig. 5B,G) or if the actin
cytoskeleton is disrupted (Fig. 5C,D,G). Interestingly, this region
does not appear to be affected dramatically by Chlprz addition
prior to NGF treatment (Fig. 5E–G; supplementary material
Table S2).
Thus, although TrkA trajectories populating region 5 are
affected by ligand-dependent receptor activation by
phosphorylation, region 2 is linked to both receptor activation
Fig. 5. Effects of drug-induced inhibition of tyrosine-kinase activity,
clathrin-coated pit formation and actin meshwork on ACP–TrkA lateral
dynamics. (A–F) 2D distribution of c and D for S-Qdot-labelled ACP–TrkA
trajectories, as obtained by MSS-TAD analysis (as in Fig. 4A–E; same colour
scale as in Fig. 4F). The cells were either unstimulated (left panels) or
stimulated (right panels) with NGF, and were treated with K252a
(A,B; n5854 and 2077, respectively), Chlprz (C,D; n51152 and 1546,
respectively) or Cyt-D (E,F; n51274 and 686, respectively). (G) Stack
column graph representing the frequency percentage of different dynamics
modes for ACP–TrkA receptors under different treatments, calculated as for
Fig. 4G (data reported in supplementary material Table S2). The first two
stacked-bars, are the same as in Fig. 4G (for comparison).
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and CCP formation. We may infer that region 5 includes
trajectories involved in the formation of signalling platforms
whose motion is hindered most probably by interactions with
downstream signalling effectors, possibly linked to actin
filaments (Fig. 6). Conversely, region 2 probably corresponds
to trajectories of receptors assembling into precursors of
signalling endosomes at the plasma membrane (Fig. 6).
Interestingly, incubation with NGF R100E causes regions 2 and
5 to be populated to the same extent as in the NGF case
(Fig. 4B,C,G); this does not occur for proNGF and NT-3
(Fig. 4D,E,G). This demonstrates that NGF R100E can induce
TrkA activation and formation of signalling endosomes similarly
to NGF. Thus, the SPT analysis of TrkA trajectories activated by
NGF or by the HSAN V-related NGF R100E mutant confirms
that the two proteins share a similar binding mechanism to TrkA;
identical conclusions have been drawn from different studies
(Capsoni et al., 2011). Instead, proNGF and NT-3 induce very
different TrkA dynamics. In vitro proNGF shows a lower binding
affinity to TrkA than NGF (supplementary material Fig. S2)
(Paoletti et al., 2009; Covaceuszach et al., 2010); consistently, in
vivo proNGF induces lower receptor phosphorylation levels than
NGF (Fahnestock et al., 2004). We find that proNGF induces a
lower number of TrkA receptor trajectories populating regions 5
and 2 (Fig. 4D) that correspond, in our interpretation, to
signalling platforms and signalling endosome precursors,
respectively. This is consistent with its lower activity through
TrkA in vivo. The actual contribution of p75NTR co-receptor in
modulating proNGF-induced TrkA dynamics remains to be
elucidated, given the very low levels of p75NTR in SH-SY5Y
cells (supplementary material Fig. S5). It could be that the co-
expression of p75NTR enhances proNGF-dependent responses,
which could explain the neurotrophic activity displayed by
proNGF in vivo (Fahnestock et al., 2001). As for NT-3, in vitro
data show that it binds to TrkA with a binding affinity that is two
orders of magnitude lower than NGF (supplementary material
Fig. S2). However, increased doses of NT-3 have been shown to
activate TrkA and downstream effectors in vivo (Harrington et al.,
2011; Kuruvilla et al., 2004). Our data show that a 10-fold molar
excess of NT-3 over NGF and proNGF is able to activate TrkA,
more than proNGF, but less than NGF (region 5 in Fig. 4E,G).
However, NT-3 does not cause an enrichment of trajectories that
we associate with the assembly of signalling endosomes; this can
Fig. 6. Model illustrating the fingerprinting effect. This schematic view of possible states of TrkA in its different dynamics modes (numbers refer to the regions
in Fig. 4A and Fig. 5A) summarizing our conclusions (see text for further discussion). Insets show a typical trajectory for each dynamics mode, enlarged when
necessary to appreciate its details. The population in regions 1 and 7 decreases upon each treatment; changes induced by ligands and/or drug treatments with
respect to the unstimulated case are also indicated schematically. Large ellipses represent TrkA extracellular domains (red if bound, grey if unbound), small
ellipses the intracellular domains (red if phosphorylated, grey if inactive). The membrane bilayer is in blue; brown rectangles represent clathrin; brown lines
represent actin filaments; yellow and green shapes represent possible intracellular effectors.
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be deduced from the lack of trajectories in region 2 (but also 4
and 6) and from the lower ,t. of TAD events (see Table 1 and
supplementary material Table S1), comparable to the case where
the formation of CCP (and hence of early endosomes) is inhibited
by Chlprz. Failure of NT-3 to induce phosphorylated TrkA
internalization (see supplementary material Fig. S2) (Harrington
et al., 2011; Kuruvilla et al., 2004) may represent the functional
significance of this observed NT-3 signature at the level of
receptor dynamics.
Region 3 includes trajectories with a higher degree of
confinement than region 2 (0.1,c,0.35), but with a slightly
higher D (761023 to 0.9610–1 mm2/second). The addition of all
TrkA ligands causes an enrichment of trajectories populating
region 3, with a similar trend to that of region 2 (compare B–E
with A in Fig. 4). The same region is highly populated when the
non-stimulated ACP–TrkA receptor is inactivated with K252a
(from ,6% in resting conditions to 15% upon K252a
administration; supplementary material Table S2). Moreover
this region, similarly to region 2, is sensitive to Chlprz treatment,
and is highly depopulated by this drug either in the presence or
absence of NGF (Fig. 5E–G). These data suggest that region 3 is
populated mainly by receptors primed for constitutive recycling,
internalization, degradation or a feedback loop regulating the
functional response to ligands (Fig. 6). It was quite surprising to
find out that NGF R100E populates region 3 slightly more than
NGF (Fig. 4B,C,G). NGF and NGF R100E indeed share a similar
activation of TrkA receptor; however, these growth factors
demonstrate a different extent of PLCc pathway activation (see
supplementary material Fig. S2) (Capsoni et al., 2011). Clearly,
this functional difference corresponds to the subtle modification
of the D-c distribution reported in Fig. 4C. The precise reasons
why NGF R100E addition increases the number of recycling
receptors compared with NGF remains to be explored. Still, our
SPT analysis method provides a very sensitive measure of TrkA
receptor activation, and makes it possible to detect minimal
differences between various ligands.
Regions 4 and 6 include the slowest-diffusing trajectories
down to very low c values corresponding to the immobile ones;
these are reported in Table 1 and their confinement length was
analysed (Fig. 2B; Fig. 3A–C; supplementary material Fig.
S3A,C,E). Given the susceptibility of these trajectories to
Chlprz treatment (Fig. 5C,D,G), they probably correspond to
ACP–TrkA multimers inside more mature signalling endosomes
ready to be actively internalized (Fig. 6). Indeed, these regions
are mostly populated when incubating TrkA with NGF and NGF
R100E ligands (Fig. 4B,C), with the two ligands leading to the
highest TrkA internalization, but not with proNGF and NT-3
(Fig. 4D,E).
Finally, regions 7 and 8 include drifted trajectories with c.0.5
and can be fast (region 7) or slow (region 8). The fast drifted
trajectories are reduced by ligand addition, similar to the
trajectories in region 1 (supplementary material Table S2), and
can therefore be considered as the high-c tail of the fast freely
diffusing population. As for the slow drifted population of region
8, it is very poorly populated in almost all considered conditions.
These trajectories might stem from ACP–TrkA receptor
molecules localized within internalized sub-membrane vesicles
(Fig. 6), which are still detectable because of the high
fluorescence quantum yield of Qdots and the higher number of
Qdots present within such vesicles.
The actin meshwork disruption caused by Cyt-D treatment
mostly induces a higher population in region 3, which we
interpret as the group of inactive receptors that are constitutively
recycled and possibly degraded. Moreover, we observed a small
shift towards lower values of the characteristic D value of the
faster population. These data are apparently not in agreement
with the fence-and-pickets model (Kusumi et al., 2005):
according to that model, when inducing a partial actin
depolymerization by short drug treatment, there are less actin
filaments barriers so that an increase in receptor diffusion can be
observed (Suzuki et al., 2007), eventually determining an
enhanced availability of receptor molecules for signalling
(Treanor et al., 2010). However, we should note that different
receptors may have distinct sensitivities to disruption of the sub-
membrane actin meshwork; moreover, the actin disruption
performed in our experiments was not partial (see Materials
and Methods and supplementary material Fig. S3C). It is in
principle possible that after prolonged drug treatment the TrkA
‘monomers reservoir’, normally maintained by a functional actin
meshwork, undergoes processes such as constitutive
internalization, while still being available for signalling events
upon ligand treatments (Fig. 5E,F). Indeed, we do see an
increased fraction of either confined or immobile receptors
upon NGF administration, in the presence of Cyt-D (Fig. 5F,G;
supplementary material Fig. S4E–F; Table 1), although the
confinement and diffusivity features of signalling platforms
(normally populating region 5) and signalling endosomes
precursors (normally within regions 2, 4, 6) are here
completely shifted by the drug treatment.
From a general perspective, the main conclusion from these
experiments is that receptor dynamics in the plasma membrane
carries a signature tracing back to its specific activation event.
TrkA lateral mobility was shown to be a sensitive predictor of
full, partial, or biased agonists that bind to the receptor. The
ligand signature results from a different binding affinity of a
given ligand for the receptor, from the specific intracellular
effectors recruited in the signalling platforms and/or from the
formation of endosome precursors. The second conclusion that
we can draw from these experiments is that the specific
biological outcomes induced by different ligands binding to the
same receptor can be reliably traced back to the earliest events of
receptor activation, namely the initial receptor membrane
movements triggered upon binding. Indeed, different TrkA
agonists, all binding TrkA specifically and activating, through
TrkA, different cellular processes, trigger distinct trajectory
patterns of TrkA molecules at the cell membrane.
How the ligand signature of TrkA dynamics is influenced by
its co-receptor p75NTR is an important question that remains to be
addressed. Answering such a question requires the ability to
perform SPT of the two receptors simultaneously. Another open
issue is the generalization of the dynamic fingerprint concept to
other receptors: hypothetically, there may be a causal correlation
between dynamic fingerprints and signalling pathways.
Materials and Methods
Cell surface labelling of ACP–TrkA expressed in living SH-SY5Y cells
SH-SY5Y cells were transfected with ACP–TrkA construct (Callegari et al., 2012).
Between 3 and 5 hours after transfection, cells were trypsinized and transferred
into Willco-dishH glass-bottom dishes. Cells were allowed to attach overnight,
then serum starved for 2 hours, and incubated for 30 minutes at 37 C˚ in DMEM-
F12 with 0.5% BSA, containing 1.0 mM of Sfp synthase (New England Biolabs),
10 mM MgCl2 and variable amounts of coenzyme A derivative depending on the
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experiment. For the labelling with S-Qdots for single-molecule experiments, 5 mM
biotin-CoA was used, then cells were washed twice in PBS before incubation for
2 minutes at room temperature with 2 nM S-Qdot (QdotH 655 streptavidin
conjugate; Invitrogen) in borate buffer pH 8.3, 0.5% BSA and 215 mM sucrose
(Bannai et al., 2007). These conditions ensured a minimal non-specific adhesion of
S-Qdots to the glass surface. To achieve a ‘bulk’ labelling of ACP–TrkA construct
at the plasma membrane (Fig. 1A), 20 nM S-Qdot was incubated for 15 minutes,
then cells were fixed, mounted in DAPI-containing VectaShield and imaged using
an Olympus FV1000 confocal microscope with a 406 objective and the 488 nm
argon laser line to image both the GFP and the S-Qdot655 channels and a 405 nm
laser for DAPI excitation. For labelling with Atto633 fluorophore, 5 nM CoA–
Atto633 conjugate was used as a substrate in the reaction mix to yield complete
receptor labelling. Cells were imaged in imaging medium (20 mM HEPES,
6.6 mM D-glucose, 2 mM L-glutamine, 1 mM sodium pyruvate and 0.5% B-27
supplement in MEM medium) after extensive washing (8–10 times with PBS).
Notably, no significant differences in receptor immobile populations and in D
distributions were detected when labelling the receptor with either monovalent
Atto633–CoA fluorophore or multivalent S-Qdots. This observation supports the
idea that potential S-Qdots-mediated receptor crosslinking is minimized under our
experimental conditions (low Qdot concentration, use of BSA in the labelling
reaction and analysis of cells displaying low-level expression of receptor).
Synthesis of biotin-maleimide
Biotin (10 mg) dissolved in DMF (250 ml), NHS (1.1 eq), 2-aminoethylmaleimide
(1.1 eq) and EDC (1.2 eq) were mixed, and the solution stirred for 4 hours at 25 C˚.
The product was purified by semi-preparative RP-HPLC.
Synthesis of CoA-biotin and CoA-Atto633
Coenzyme A (10 nmol), dissolved in DMF (2 ml), was mixed with the appropriate
maleimido derivative (20 nmol) in DMF (10 mM). The solution was stirred at
35 C˚ for 4 hours. The product was purified by RP-HPLC (column: Phenomenex
Fusion 15064.6. Solvents: ammonium formate 5 mM/acetonitrile).
Ligand treatments
Transfected SH-SY5Y cells were treated with different ligands: native mouse NGF
(Alomone Labs, 125 ng/ml), recombinant human pro-NGF (300 ng/ml),
recombinant human NGF R100E (125 ng/ml) and recombinant human NT-3
(Alomone Labs, 1000 ng/ml). Equimolar doses of NGF, NGF R100E and proNGF
were used, and NT-3 was administered in a 10-fold molar excess over NGF, as
reported (Harrington et al., 2011; Kuruvilla et al., 2004). Recombinant proNGF
and NGF R100E mutant were expressed in E. coli and purified as described
(Covaceuszach et al., 2010). All ligands were added as two-times concentrated,
pre-warmed (37 C˚) solutions to an equal volume of imaging medium directly into
Willco-dishH glass-bottomed chambers used for microscopy. Cells were always
imaged for a maximum of 15 minutes upon ligand addition.
Drug treatments
For the inhibition of TrkA kinase activity, ACP–TrkA-expressing SH-SY5Y cells
were treated overnight with 200 nM K252a (Sigma-Aldrich) before the labelling
reaction. To block the endocytosis machinery, transfected cells were exposed to
25 mM Chlprz (Sigma-Aldrich) during the ACP-labelling reaction. In order to
disrupt the actin meshwork at the plasma membrane, transfected cells were treated
with 1 mM Cyt-D (Sigma-Aldrich) for 2 hours, during the serum starvation
preceding the cell surface labelling of ACP–TrkA. Each drug was also added to the
imaging medium, keeping the Cyt-D concentration unaltered, while K252a was
lowered to 100 nM in the labelling reaction and imaging medium and Chlprz was
increased to 50 mM in the imaging medium.
Microscope image acquisition
Cells prepared as described above were immediately imaged at 37 C˚, 5% CO2 with
a Leica DM6000 microscope equipped with Leica TIRF-AM module, incubator
chamber, electron multiplying charge-coupled-device camera (ImagEM C9100-13,
Hamamatsu), and 1006oil immersion objective (NA 1.47). TIRF time series were
acquired on a ROI with constant size of 1446152 pixels (32.7634.5 mm) within
the basal membrane of each cell, using the 488 nm laser line with a Qdot655/10
emission filter, or the 632 nm laser line with a Cy5 Leica1152303 emission filter,
and penetration depth set at 90 nm. The integration time per frame was
21 mseconds and typical time series lasted 3000 frames. The lag time between
two consecutive frames was minimized to the integration time (21 mseconds) by
using the overlapping mode of the CCD camera with the reduced ROI. Cells with
low density of Qdots where chosen to calculate trajectories.
Data analysis
Detection and localization of S-Qdots conjugated to biotinylated ACP–TrkA or
CoA-Atto633-labeled ACP–TrkA, linking and merging of the trajectories was
done using Imaris software (Bitplane Scientific Software). We found the following
software parameters to be optimal to overcome splitting caused by Qdot blinking:
estimated spot diameter 0.8 mm, Brownian motion algorithm, max spot distance
1 mm, max gap size 30 frames. Visual inspection of the resulting trajectories and
their manual editing was performed in case of linking mistakes by the algorithm.
Spots of fluorophores non-specifically adhered to the glass outside the cell were
discarded by considering the merge of the TIRF over the DIC image. Qdots non-
specifically adhered to the glass under the basal membrane of the investigated cells
were found to be negligible or anyway not interfering with TrkA trajectories
analysis (supplementary material Fig. S6).
Further analyses on the trajectories were carried out almost automatically using
codes written in MatLab, which performed the analyses described in
supplementary material Fig. S7 and summarized in the following. The
trajectories acquired in the case of CoA–Atto633-labelled ACP–TrkA were
relatively short and very numerous: they were analysed all together, only
considering their average short-lag-time diffusion coefficient D6s.e. as deduced
from the initial angular coefficient of the mean square displacement (MSD)
(Callegari et al., 2012), and considering the average intensity6s.d. on whole
trajectories (Fig. 2D). In the case of Qdot-labelled receptors, we first used the
moment scaling spectrum (MSS) analysis (Ewers et al., 2005) in order to separate
self-similar from multimodal trajectories; the latter were analysed using an
algorithm for the detection of non-random transient confinement zones (Simson
et al, 1995), similar to the stimulation-induced transient arrest of lateral diffusion
(STALL) method (Suzuki et al., 2007). Our algorithm is here referred to as TAD
(transient arrest of diffusion) because such events were observed also for the
TrkA receptor in the absence of any stimulation. For all trajectories and
subtrajectories (determined by TAD analysis) we calculated the MSD, the MSS
and the average spot intensity ,I.6s.d., also checking if the diffusing
subtrajectories and the confinement events predicted by TAD were correct. The
confinement length parameter L was calculated using the MSD fit for ‘confined’
trajectories only if those were long enough to explore the confinement area
substantially (Callegari et al., 2012); the sub/super-diffusive coefficient c with its
uncertainty was determined by a fit of the MSS. A schematic view of this analysis
and more details about it can be found in supplementary material Fig. S7 and its
caption.
All 1D or 2D distributions or histograms reported here were evaluated weighting
each (sub)trajectory by the number of spots composing it and, except where stated
differently, their integrals were normalized to 1. Except for L, the uncertainties of
the parameters were considered by summing 1D or 2D Gaussians for computing
the experimental distributions. A colour code in logarithmic scale, with the
maximum normalized to 1, allowed visualization of the 2D distributions.
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